Here is an English version of the campaign / declaration text you asked me to prepare, adapted into clear English while keeping your ideas and numbers (including the price range of flow‑meters) intact.[1][2][3][4] You can shorten or edit this for a press release, website, or social media.

---

CAMPAIGN DECLARATION DRAFT

“Blood Flow Is Your Right” – Prevent Heart Attacks, Not Just Finance the Epidemic

Heart and vascular diseases are limiting the lives of millions of people worldwide and in Türkiye, and they are economically and psychologically destroying hundreds of thousands of families.[5][6][4] In Türkiye alone, cardiovascular diseases rank among the top causes of death and place a multi‑billion‑lira burden on the health system every year.[5][6][4][2]

A large part of this burden comes from vessel blockages that are detected too late and from the long, expensive treatment processes that begin after a heart attack has already occurred.[6][4] Yet measuring the blood flow (flow rate) inside our vessels and explaining this to the public can both reduce unnecessary procedures and help us identify truly high‑risk people before they suffer a heart attack.[7][8][9]

1. What is a vessel flow meter and why does it matter?

A vessel flow meter (blood flow measurement device, vascular Doppler, etc.) is a hemodynamic tool that measures how much blood passes through a vessel per minute.[7][8]

• It does not only show the “image” of the vessel; it shows whether the vessel is actually carrying enough blood.[8][9]
• In vital vessels such as the coronary arteries that feed the heart, the carotid arteries in the neck, or the leg arteries, hidden narrowings can be detected through reduced blood flow and abnormal flow waveforms.[7][8][10]
• In modern cardiology, techniques such as FFR are based exactly on this logic: instead of treating only what looks narrow on an image, they decide on stents by asking “does this narrowing really reduce blood flow?”.[9][11]

Today, public awareness of concepts like blood flow, Doppler, and FFR is extremely low worldwide; in most countries, likely no more than 1–5% of the population has even heard of them, while regular home blood pressure monitoring remains limited even in rich countries.[12][13][14]

Flow‑meter devices and advanced Doppler systems currently cost roughly 2,000 to 10,000 US dollars depending on their features and usage area, and are mainly used in hospitals and by professionals.[1][15][16] However, knowing that such measurements exist and asking for them in the right setting, even once a month or once every few months, can change the game.

2. A heart attack hits not only the patient, but the whole family and the economy

Most people who suffer a heart attack do not die, but:

• Emergency care, intensive care, angiography, stents, drugs and follow‑up visits generate very high medical costs.[17][18][4]
• In Türkiye, the annual direct cost of heart failure and related interventions is estimated at around 1 billion US dollars, and with indirect costs this may reach two or three times that amount.[4][19]
• The patient’s family is forced to pay mandatory health expenses (transportation, companion costs, extra medications, additional hospital visits) plus voluntary or semi‑voluntary health expenses such as better rooms, better food, supplements, psychological support and alternative therapies.[4][2][3]
• Parents, spouses, children and even relatives like aunts/uncles take time off work, step out of production, and some lose their jobs or part of their income; children’s education and life plans are also affected.[17][4]

Total health expenditure in Türkiye exceeded 1.24 trillion TL in 2023, and 2.36 trillion TL in 2024; a major share of this goes to chronic diseases and cardiovascular care.[2][3] While the Social Security Institution (SGK) carries most of the financial burden, households still pay roughly 18–24% of total health expenditure directly out‑of‑pocket.[2][3]

In a single heart‑attack case, we therefore see:

• Mandatory costs: Hospitalization, surgery or stenting, intensive care, essential drugs, follow‑up.[17][4][2]
• Voluntary or semi‑voluntary costs: Better room, extra care, nutritional supplements, psychological support, and the travel/rent/time losses of the companion.[4][2][3]
• Hidden costs: Loss of the patient’s work capacity, family members’ lost workdays, long‑term unemployment, reduced productivity and the long shadow this casts over the children’s future.[17][4]

Behind all this, a large part of the money flows into pharmaceutical companies, medical‑device manufacturers and their supply chains, including high‑priced stents and other invasive cardiology materials.[17][18][4]

3. What would change if people knew about flow measurement?

If the public understands “blood flow” and starts demanding flow‑based evaluation instead of decisions made only on images, three things can change:

1. Earlier diagnosis and intervention before crisis:

• If Doppler‑based flow and resistance measurements are used more widely in carotid, leg and renal arteries, patients at high risk of stroke and heart attack can be identified before a catastrophic event.[7][10][20]

1. Fewer unnecessary procedures:

• Many stents and procedures that are performed just because a vessel “looks narrowed” on imaging can be eliminated if flow/FFR measurements show that blood flow is still sufficient.[9][11]
• This protects the patient from unnecessary risk and saves SGK and insurers from paying for procedures that do not truly improve blood flow.[17][9][18]

1. A critical, questioning patient population:

• If about 30–35% of the population understands flow, FFR and the idea that “flow matters more than appearance” and starts asking their doctors “Did you measure blood flow? Did you check with FFR or similar?” then the business model of “the more procedures, the more profit” pursued by drug and device lobbies will weaken.[17][21][22]

Even if people do not own such devices at home, simply knowing that blood flow can be measured and asking for this once a month or a few times a year at qualified centers can reduce:

• The number of severe, late‑stage heart attacks,
• The burden of expensive long‑term heart‑failure care,
• The mandatory and voluntary health costs that families are forced into after a crisis.[7][8][23]

4. Our call: a global and national awareness campaign on vessel blood flow

We, as physicians, researchers, patients, families and citizens, address the people of Türkiye and the international community with this call:

1. To health authorities:

• Explicitly include flow‑based assessment (vessel flow measurement, FFR and similar methods) in national cardiovascular prevention and control programs; produce educational materials in simple language for the public.[6][23]
• In SGK and other social‑insurance reimbursement policies, reward guideline‑based, flow‑oriented decision making, not unnecessary procedures.[17][6]

1. To the medical community:

• Instead of telling patients only “your vessel is blocked by X percent”, also tell them how much the blood flow is reduced and why this matters.[9][11][10]
• In medical education and conferences, give more visibility to hemodynamic‑based approaches rather than image‑only decision making.[23][9]

1. To the pharmaceutical and medical‑device industry:

• We invite you to generate profit not only through more stents and more interventions, but through smarter, less costly and more preventive solutions.[17][18][23]

1. To the public, to patients and their families:

• Just as you want to know your blood pressure, demand to know the blood flow in your vessels.
• Ask your doctor: “Did you look at the blood flow as well as the image? Is FFR or another flow‑based test necessary here?”[9][11]
• When a loved one has a heart attack, ask with a clear conscience: “Does this procedure truly improve blood flow, or is it just enlarging the bill?”

5. Final word: behind the numbers are human lives

Total health spending in Türkiye has already reached the level of trillions of lira, and cardiovascular disease is one of the largest pieces of that pie.[2][3][6] Heart failure and post‑heart‑attack care are among the most expensive fields, both for the public budget and for families.[4][19]

Every unnecessary test, every unnecessary stent, every delayed diagnosis does not only pull money from the budget; it pulls mothers, fathers, young people and children out of production and out of life.[17][4]

Therefore:

Awareness of vessel blood flow is not a technical detail. It is a core element of economic justice, patient rights and public health.

We call on the people of Türkiye, on the global public, and especially on countries and regions that carry a heavy burden of cardiovascular disease to embrace vessel‑flow and hemodynamic‑based approaches as a public right, not a luxury.

---

If you tell me your target audience (general public vs. doctors vs. policymakers), I can produce a shorter, punchier version tailored to that group.